Patents by Inventor Stephen S. Tobe

Stephen S. Tobe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7208476
    Abstract: Novel pseudopeptide analogs of the insect allatostatin neuropeptide family which possess biological activity mimicking that of the naturally occurring neuropeptides are disclosed. By addition of a hydrophobic moiety to an active portion of the allatostatin peptides, analogs are produced which exhibit an overall amphiphilic nature and which are capable of penetrating the insect cuticle while still retaining biological activity. Furthermore, by substituting sterically hindered amino acids or aromatic acids for any or all of the first, third or fifth amino acid residues of the allatostatin C-terminal pentapeptide, analogs may be produced which are resistant to degradation by insect peptidases while still retaining biological activity. The analogs may be used for insect control by disrupting critical reproductive and/or developmental processes normally regulated by allatostatins in insects.
    Type: Grant
    Filed: September 10, 2003
    Date of Patent: April 24, 2007
    Assignee: The United States of America, as represented by the Secretary of Agriculture
    Inventors: Ronald J. Nachman, Peter E. A. Teal, Christopher S. Garside, Stephen S. Tobe
  • Patent number: 7129226
    Abstract: Novel pseudopeptide analogs of the insect allatostatin neuropeptide family which possess biological activity mimicking that of the naturally occurring neuropeptides are disclosed. By addition of a hydrophobic moiety to an active portion of the allatostatin peptides, analogs are produced which exhibit an overall amphiphilic nature and which are capable of penetrating the insect cuticle while still retaining biological activity. Furthermore, by substituting sterically hindered amino acids or aromatic acids for any or all of the first, third or fifth amino acid residues of the allatostatin C-terminal pentapeptide, analogs may be produced which are resistant to degradation by insect peptidases while still retaining biological activity. The analogs may be used for insect control by disrupting critical reproductive and/or developmental processes normally regulated by allatostatins in insects.
    Type: Grant
    Filed: September 10, 2003
    Date of Patent: October 31, 2006
    Assignee: The United States of America as represented by the Secretary of Argriculture
    Inventors: Ronald J. Nachman, Peter E. A. Teal, Christopher S. Garside, Stephen S. Tobe
  • Patent number: 7078384
    Abstract: Novel pseudopeptide analogs of the insect allatostatin neuropeptide family which possess biological activity mimicking that of the naturally occurring neuropeptides are disclosed. By addition of a hydrophobic moiety to an active portion of the allatostatin peptides, analogs are produced which exhibit an overall amphiphilic nature and which are capable of penetrating the insect cuticle while still retaining biological activity. Furthermore, by substituting sterically hindered amino acids or aromatic acids for any or all of the first, third or fifth amino acid residues of the allatostatin C-terminal pentapeptide, analogs may be produced which are resistant to degradation by insect peptidases while still retaining biological activity. The analogs may be used for insect control by disrupting critical reproductive and/or developmental processes normally regulated by allatostatins in insects.
    Type: Grant
    Filed: March 10, 2003
    Date of Patent: July 18, 2006
    Assignee: The United States of America as represented by the Secretary of Agriculture
    Inventors: Ronald J. Nachman, Peter E. A. Teal, Christopher S. Garside, Stephen S. Tobe
  • Publication number: 20040229812
    Abstract: Novel pseudopeptide analogs of the insect allatostatin neuropeptide family which possess biological activity mimicking that of the naturally occurring neuropeptides are disclosed. By addition of a hydrophobic moiety to an active portion of the allatostatin peptides, analogs are produced which exhibit an overall amphiphilic nature and which are capable of penetrating the insect cuticle while still retaining biological activity. Furthermore, by substituting sterically hindered amino acids or aromatic acids for any or all of the first, third or fifth amino acid residues of the allatostatin C-terminal pentapeptide, analogs may be produced which are resistant to degradation by insect peptidases while still retaining biological activity. The analogs may be used for insect control by disrupting critical reproductive and/or developmental processes normally regulated by allatostatins in insects.
    Type: Application
    Filed: September 10, 2003
    Publication date: November 18, 2004
    Applicant: The United States of America, as represented by the Secretary of Agriculture
    Inventors: Ronald J. Nachman, Peter E. A. Teal, Christopher S. Garside, Stephen S. Tobe
  • Publication number: 20040039159
    Abstract: Novel pseudopeptide analogs of the insect allatostatin neuropeptide family which possess biological activity mimicking that of the naturally occurring neuropeptides are disclosed. By addition of a hydrophobic moiety to an active portion of the allatostatin peptides, analogs are produced which exhibit an overall amphiphilic nature and which are capable of penetrating the insect cuticle while still retaining biological activity. Furthermore, by substituting sterically hindered amino acids or aromatic acids for any or all of the first, third or fifth amino acid residues of the allatostatin C-terminal pentapeptide, analogs may be produced which are resistant to degradation by insect peptidases while still retaining biological activity. The analogs may be used for insect control by disrupting critical reproductive and/or developmental processes normally regulated by allatostatins in insects.
    Type: Application
    Filed: September 10, 2003
    Publication date: February 26, 2004
    Inventors: Ronald J. Nachman, Peter E.A. Teal, Christopher S. Garside, Stephen S. Tobe
  • Patent number: 6664371
    Abstract: Novel pseudopeptide analogs of the insect allatostain neuropeptide family which possess biological activity mimicking that of the naturally ocurring neuropepetides are disclosed. By addition of a hydrophobic moiety to an active portion of the allatostatin peptides, analogs are produced which exhibit an overall amphipilic nature and which are capable of penetrating the insect cuticle while still retaining biological activity. Furthermore, by substituting sterically hindered amino acids or aromatic acids for any or all of the first, third or fifth amino acids residues of the allatostatin C-terminal pentapeptide, analogs may be produced which are resistant to degradation by insect peptidases while still retaining biological activity. The analogs may be used for insect control by disrupting critical reproductive and/or developmental processes normally regulated by allatostatins in insects.
    Type: Grant
    Filed: January 19, 2001
    Date of Patent: December 16, 2003
    Assignee: The United States of America as represented by the Secretary of Agriculture
    Inventors: Ronald J. Nachman, Peter E. A. Teal, Christopher S. Garside, Stephen S. Tobe
  • Publication number: 20030161857
    Abstract: Novel pseudopeptide analogs of the insect allatostatin neuropeptide family which possess biological activity mimicking that of the naturally occurring neuropeptides are disclosed. By addition of a hydrophobic moiety to an active portion of the allatostatin peptides, analogs are produced which exhibit an overall amphiphilic nature and which are capable of penetrating the insect cuticle while still retaining biological activity. Furthermore, by substituting sterically hindered amino acids or aromatic acids for any or all of the first, third or fifth amino acid residues of the allatostatin C-terminal pentapeptide, analogs may be produced which are resistant to degradation by insect peptidases while still retaining biological activity. The analogs may be used for insect control by disrupting critical reproductive and/or developmental processes normally regulated by allatostatins in insects.
    Type: Application
    Filed: March 10, 2003
    Publication date: August 28, 2003
    Applicant: United States of America, as represented by the Secretary of Agriculture
    Inventors: Ronald J. Nachman, Peter E. A. Teal, Christopher S. Garside, Stephen S. Tobe
  • Patent number: 6207643
    Abstract: Novel pseudopeptide analogs of the insect allatostatin neuropeptide family which possess biological activity mimicking that of the naturally occurring neuropeptides are disclosed. By addition of a hydrophobic moiety to an active portion of the allatostatin peptides, analogs are produced which exhibit an overall amphiphilic nature and which are capable of penetrating the insect cuticle while still retaining biological activity. Furthermore, by substituting sterically hindered amino acids or aromatic acids for any or all of the first, third or fifth amino acid residues of the allatostatin C-terminal pentapeptide, analogs may be produced which are resistant to degradation by insect peptidases while still retaining biological activity. The analogs may be used for insect control by disrupting critical reproductive and/or developmental processes normally regulated by allatostatins in insects.
    Type: Grant
    Filed: November 13, 1998
    Date of Patent: March 27, 2001
    Assignee: The United States of America as represented by the Secretary of Agriculture
    Inventors: Ronald J. Nachman, Peter E. A. Teal, Christopher S. Garside, Stephen S. Tobe